Published in Virology on November 25, 1999
Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc Natl Acad Sci U S A (2000) 4.39
Identification of a heparin-binding motif on adeno-associated virus type 2 capsids. J Virol (2003) 3.25
Recombinant adeno-associated virus transduction and integration. Mol Ther (2008) 1.44
Intracellular transport of recombinant adeno-associated virus vectors. Gene Ther (2012) 1.44
Endocytosis of adeno-associated virus type 5 leads to accumulation of virus particles in the Golgi compartment. J Virol (2002) 1.35
Adeno-associated virus-2 and its primary cellular receptor--Cryo-EM structure of a heparin complex. Virology (2009) 1.23
Comparison of the transcription profile of simian parvovirus with that of the human erythrovirus B19 reveals a number of unique features. J Virol (2004) 1.21
Integrin alpha3beta1 is an alternative cellular receptor for adenovirus serotype 5. J Virol (2003) 0.97
Pathways of cell infection by parvoviruses and adeno-associated viruses. J Virol (2004) 0.89
Effect of inhibition of dynein function and microtubule-altering drugs on AAV2 transduction. Virology (2007) 0.84
Electron microscopy analysis of a disaccharide analog complex reveals receptor interactions of adeno-associated virus. J Struct Biol (2013) 0.79
CliniWeb: managing clinical information on the World Wide Web. J Am Med Inform Assoc (1996) 4.13
Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer. J Biol Chem (2001) 3.15
Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity. J Virol (2001) 3.11
Nonequivalent nuclear location of immunoglobulin alleles in B lymphocytes. Nat Immunol (2001) 2.83
Targeting of Ikaros to pericentromeric heterochromatin by direct DNA binding. Genes Dev (2000) 2.55
Helios, a T cell-restricted Ikaros family member that quantitatively associates with Ikaros at centromeric heterochromatin. Genes Dev (1998) 2.37
Nucleotide sequencing and generation of an infectious clone of adeno-associated virus 3. Virology (1996) 2.26
Detection of influenza A(H3N2) virus in children with suspected mumps during winter 2014/15 in England. Euro Surveill (2015) 2.19
Adeno-associated virus type 2 binds to a 150-kilodalton cell membrane glycoprotein. Virology (1996) 1.97
Influence of Pseudomonas aeruginosa exoproducts on virulence factor production in Burkholderia cepacia: evidence of interspecies communication. J Bacteriol (1995) 1.74
Adeno-associated virus (AAV)-3-based vectors transduce haematopoietic cells not susceptible to transduction with AAV-2-based vectors. J Gen Virol (2000) 1.73
The United Kingdom public health response to an imported laboratory confirmed case of a novel coronavirus in September 2012. Euro Surveill (2012) 1.67
Clinical relevance of parvovirus B19 as a cause of anemia in patients with human immunodeficiency virus infection. J Infect Dis (1997) 1.63
Inhibitory action of fatty acids on the growth of Neisseria gonorrhoeae. Infect Immun (1977) 1.53
Fabrication of an ocular prosthesis. J Prosthet Dent (1970) 1.32
Cryo-electron microscopy studies of empty capsids of human parvovirus B19 complexed with its cellular receptor. Proc Natl Acad Sci U S A (1996) 1.29
The interaction of heparin sulfate and adeno-associated virus 2. Virology (2000) 1.28
Identification of a novel simian parvovirus in cynomolgus monkeys with severe anemia. A paradigm of human B19 parvovirus infection. J Clin Invest (1994) 1.26
Many multipotential gene-marked progenitor or stem cell clones contribute to hematopoiesis in nonhuman primates. Blood (2000) 1.25
A 110-kDa nuclear shuttle protein, nucleolin, specifically binds to adeno-associated virus type 2 (AAV-2) capsid. Virology (1999) 1.25
Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome. Blood (2001) 1.24
Clinical considerations improving obturator treatment. J Prosthet Dent (1970) 1.23
An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils. J Pharmacol Exp Ther (1989) 1.22
Mini-chromosomes derived from the human Y chromosome by telomere directed chromosome breakage. Proc Natl Acad Sci U S A (1996) 1.18
Brief report: no evidence for parvovirus B19 or hepatitis E virus as a cause of acute liver failure. Dig Dis Sci (2006) 1.16
Review of the effect of measles vaccination on the epidemiology of SSPE. Int J Epidemiol (2007) 1.15
Rhesus and pig-tailed macaque parvoviruses: identification of two new members of the erythrovirus genus in monkeys. Virology (2000) 1.15
Fabrication of a hollow-bulb obturator. J Prosthet Dent (1969) 1.14
Heparin prevents vascular smooth muscle cell progression through the G1 phase of the cell cycle. J Biol Chem (1989) 1.13
Reconstruction considerations for severe dental attrition. J Prosthet Dent (1980) 1.11
Retracted GB virus C/hepatitis G virus replicates in human haematopoietic cells and vascular endothelial cells. J Gen Virol (2000) 1.07
Peripheral consideration in improving obturator retention. J Prosthet Dent (1968) 1.04
Reliability and validity of four instruments for measuring lumbar spine and pelvic positions. Phys Ther (1986) 1.04
Adeno-associated virus 2 co-receptors? Nat Med (1999) 1.04
Prevalence of the newly described human circovirus, TTV, in United States blood donors. Transfusion (2000) 1.01
Life-threatening parvovirus B19-associated myocarditis and cardiac transplantation as possible therapy: two case reports. Clin Infect Dis (1998) 1.00
Rabaptin-5 is a novel fusion partner to platelet-derived growth factor beta receptor in chronic myelomonocytic leukemia. Blood (2001) 0.99
Experimental infection of cynomolgus monkeys with simian parvovirus. J Virol (1997) 0.98
Aging effects on the elastin composition in the extracellular matrix of cultured rat aortic smooth muscle cells. In Vitro Cell Dev Biol (1985) 0.96
Adherence of human basophils to cultured umbilical vein endothelial cells. J Clin Invest (1988) 0.96
Clinical and epidemiological features of simian parvovirus infection in cynomolgus macaques with severe anemia. Lab Anim Sci (1996) 0.95
Fabrication of a nose prosthesis. J Prosthet Dent (1971) 0.94
Increased expression of tissue inhibitor of metalloproteinases type 1 (TIMP-1) in a more tumourigenic colon cancer cell line. J Pathol (2000) 0.92
Fabrication of orbital prosthesis. J Prosthet Dent (1969) 0.90
Prokaryotic expression of a VP1 polypeptide antigen for diagnosis by a human parvovirus B19 antibody enzyme immunoassay. J Clin Microbiol (1992) 0.89
The prevalence of antibody to human parvovirus B19 in Rio de Janeiro, Brazil. Rev Inst Med Trop Sao Paulo (1991) 0.89
Symptomatic parvovirus B19 infection and heat-treated factor IX concentrate. Lancet (1989) 0.87
Differential mRNA regulation of integrin subunits alpha V, beta 1, beta 3, and beta 5 during mouse embryonic organogenesis. Cell Adhes Commun (1995) 0.87
Detection of B19 parvovirus in human fetal tissues by electron microscopy. J Med Virol (1991) 0.86
In vivo marking of rhesus monkey lymphocytes by adeno-associated viral vectors: direct comparison with retroviral vectors. Blood (1999) 0.85
Detection of B19 parvovirus in human fetal tissues by in situ hybridisation. J Med Virol (1991) 0.84
Early and late gene expression in UT-7 cells infected with B19 parvovirus. Virology (1993) 0.84
Risk factors for hepatitis C fibrosis: a prospective study of United States veterans compared with nonveterans. J Viral Hepat (2007) 0.83
Evaluation of the time resolved fluorescence immunoassay (TRFIA) for the detection of varicella zoster virus (VZV) antibodies following vaccination of healthcare workers. J Virol Methods (2010) 0.83
In situ hybridisation and in situ polymerase chain reaction detection of parvovirus B19 DNA within cells. J Virol Methods (1994) 0.82
Blind comparison of Abbott and Dupont HIV antigen ELISA tests for detecting antigenaemia in asymptomatic human immunodeficiency virus antibody positive homosexual men. J Clin Pathol (1990) 0.82
Fabrication of ear prosthesis. J Prosthet Dent (1969) 0.81
Planning for, implementing and assessing the impact of health promotion and behaviour change interventions: a way forward for health psychologists. Health Psychol Rev (2013) 0.81
Mechanisms of transcriptional regulation in lymphocyte progenitors: insight from an analysis of the terminal transferase promoter. Cold Spring Harb Symp Quant Biol (1999) 0.81
Fabrication of an alloplastic cranioimplant. J Prosthet Dent (1970) 0.80
Congenital anemia caused by parvovirus B19 infection. Pediatr Infect Dis J (2000) 0.80
Physical therapy for migraine-related vestibulopathy and vestibular dysfunction with history of migraine. Laryngoscope (2000) 0.80
Integrin regulatory switching in development: oscillation of beta 5 integrin mRNA expression during epithelial-mesenchymal interactions in tooth development. Int J Dev Biol (1994) 0.79
GB virus C/Hepatitis G virus infection is frequent in American children and young adults. Clin Infect Dis (2000) 0.79
Regulation of expression of the growth-state-related genes 2F1 and 2A9 during entry of quiescent smooth muscle cells into the cell cycle. J Cell Biochem (1991) 0.79
Morphology and antigenicity of recombinant B19 parvovirus capsids expressed in transfected COS-7 cells. J Gen Virol (1995) 0.79
On-line global/WHO-European regional measles nucleotide surveillance. Euro Surveill (2008) 0.78
Complement C4 protein expression by rat hepatic stellate cells. J Immunol (1996) 0.78
Effect of ventriculectomy versus ventriculocordectomy on upper airway noise in draught horses with recurrent laryngeal neuropathy. Equine Vet J (2009) 0.78
Quantitative analysis of neutralizing immune responses to human parvovirus B19 using a novel reverse transcriptase-polymerase chain reaction-based assay. J Infect Dis (1999) 0.78
Laboratory infection with human parvovirus B19. J Infect (1992) 0.78
Human parvovirus B19 can infect cynomolgus monkey marrow cells in tissue culture. J Virol (1995) 0.78
Dynamic opening device for mandibular trismus. J Prosthet Dent (1968) 0.77
Lack of evidence for parvovirus B19 viraemia in children with chronic neutropenia. Br J Haematol (1994) 0.77
Sequencing and characterization of A-2 plaque virus: A new member of the Picornaviridae family. Virology (2000) 0.77
Vitamin E decreases hepatic levels of aldehyde-derived peroxidation products in rats with iron overload. Am J Physiol (1996) 0.76
Primary T lymphocytes as targets for gene therapy. J Hematother Stem Cell Res (2000) 0.76
Long-term transmission of measles virus in Central and continental Western Europe. Virus Genes (2015) 0.76
A woman with suspected subacute sclerosing panencephalitis (SSPE). J Clin Virol (2010) 0.76
The measurement of self-control in children: validation of the Self-Control Rating Scale. J Pediatr Psychol (1984) 0.75
Genetic hemochromatosis and Wilson's disease: role for oxidant stress? Hepatology (1995) 0.75
New molecular diagnostic tests for two congenital forms of anemia. J Clin Lab Anal (1997) 0.75
A woman with ataxia, nystagmus and headache. J Clin Virol (2013) 0.75
Supportive metallic implant for autogenous mandibular graft. J Prosthet Dent (1971) 0.75
Industrial allergens. Aust Fam Physician (1977) 0.75
An adaptable optimal controller for electric wheelchairs. J Rehabil Res Dev (1987) 0.75
Some toxicological problems in a rubber industry. Med J Aust (1969) 0.75
Mepivacaine local anaesthetic duration in equine palmar digital nerve blocks. Equine Vet J (2004) 0.75
Complete denture treatment in patients with resected mandibles. J Prosthet Dent (1969) 0.75
Technique of splint contouring in resected edentulous mandibular reconstruction. J Prosthet Dent (1969) 0.75
Pancytopenia secondary to parvovirus B19 infection in a child with acute lymphoblastic leukemia, mimicking leukemic relapse. Am J Hematol (1995) 0.75
Lead study questioned. Pediatrics (1982) 0.75
Transcription-positive cofactor 4 enhances rescue of adeno-associated virus genome from an infectious clone. J Gen Virol (1998) 0.75
Chemotherapy of leprosy; "bubble" or "calendar" packs for the administration of rifampin, dapsone, clofazimine, or prothionamide/ethionamide. Int J Lepr Other Mycobact Dis (1983) 0.75
Factor analysis of the WISC-R for the gifted. J Educ Psychol (1980) 0.75
Possible roles of phosphoproteins in mineralization. CDS Rev (1984) 0.75